KKI 7
| Code | Size | Price |
|---|
| TAR-T32399-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T32399-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Documents
Further Information
Bioactivity:
KKI 7 is a peptide analog.
CAS:
113584-01-3
Molecular Weight:
758.91
Purity:
0.98
SMILES:
[C@H](CC1=CC=CC=C1)(C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CCC(N)=O)C(N)=O)=O)C(C)C)=O)CO)=O)CCCNC(=N)N)=O)NC(CC2CCCCC2)=O
References
Okunishi H, Spragg J, Burton J. In vivo assay of specific kallikrein inhibitors. Agents Actions Suppl. 1987;22:381-90. PubMed PMID: 3481213.
Okunishi H, Spragg J, Burton J, Toda N. In vivo inhibition of tissue kallikreins by kininogen sequence analogue peptides. Adv Exp Med Biol. 1989;247B:23-8. PubMed PMID: 2481944.
Rebuffat P, Neri G, Bah?elioglu M, Malendowicz LK, Nussdorfer GG. Prolonged kallikrein inhibition does not affect the basal growth and secretory capacity of rat adrenal cortex, but enhances mineralo- and glucocorticoid response to ACTH and handling stress. Histol Histopathol. 2000 Apr;15(2):441-4. doi: 10.14670/HH-15.441. PubMed PMID: 10809362.
Burton J, Benetos A. The design of specific inhibitors of tissue kallikrein and their effect on the blood pressure of the rat. Adv Exp Med Biol. 1989;247B:9-13. PubMed PMID: 2610106.